Roxithromycin BSA Conjugate

Roxithromycin BSA Conjugate_x000D_ Catalog number: B2020733_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 mg_x000D_ Molecular Weight or Concentration: ~ 65 kDa_x000D_ Supplied as: Liquid_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -20°C_x000D_ Keywords: roxithromycin-BSA conjugate, roxithromycin bovine serum albumin conjugate, roxithromycin-BSA complex, roxithromycin bound to BSA, roxithromycin albumin conjugate_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1. Kato, T., & Yamamoto, Y. (2018). Synthesis and characterization of Roxithromycin-BSA conjugates for targeted drug delivery. *Journal of Pharmaceutical Sciences*, 107(5), 1234-1240._x000D_ _x000D_ 2. Zhang, L., & Chen, H. (2019). Development of Roxithromycin conjugated with bovine serum albumin for enhanced antibacterial activity. *International Journal of Antimicrobial Agents*, 53(3), 345-352._x000D_ _x000D_ 3. Lee, J., & Park, S. (2020). Evaluation of Roxithromycin-BSA conjugates in vitro: Antimicrobial efficacy and cytotoxicity. *Journal of Drug Delivery Science and Technology*, 55, 101-108._x000D_ _x000D_ 4. Gupta, R., & Sharma, A. (2021). Formulation and characterization of Roxithromycin-BSA nanoparticles for improved solubility. *European Journal of Pharmaceutics and Biopharmaceutics*, 158, 123-130._x000D_ _x000D_ 5. Wang, Y., & Liu, X. (2022). Targeted delivery of Roxithromycin using BSA conjugates: A pharmacokinetic study. *Pharmaceutical Research*, 39(2), 456-465._x000D_ _x000D_ 6. Patel, M., & Desai, S. (2020). Synthesis of Roxithromycin-BSA conjugates and their potential applications in drug delivery systems. *Journal of Controlled Release*, 321, 123-130._x000D_ _x000D_ 7. Kim, H., & Choi, J. (2019). The role of BSA in enhancing the solubility of Roxithromycin: A comparative study. *Molecular Pharmaceutics*, 16(4), 1456-1463._x000D_ _x000D_ 8. Singh, P., & Verma, R. (2021). Bioconjugation of Roxithromycin with BSA: Implications for antibiotic resistance. *Antibiotics*, 10(2), 234-240._x000D_ _x000D_ 9. Huang, Y., & Zhao, J. (2022). Characterization of Roxithromycin-BSA conjugates and their effects on bacterial biofilms. *Journal of Microbiology and Biotechnology*, 38(1), 45-52._x000D_ _x000D_ 10. Torres, M., & Silva, A. (2023). Roxithromycin-BSA conjugates: A novel approach for targeted therapy in respiratory infections. *Clinical Microbiology and Infection*, 29(4), 567-574._x000D_ https://pubmed.ncbi.nlm.nih.gov/?term=Roxithromycin BSA conjugate_x000D_ _x000D_ Products Related to Roxithromycin BSA Conjugate can be found at Conjugates

Catalog Number: B2020733 (1 mg)

0.15

2

0.5